[Frameworks for responsible anticoagulation care: a contribution to a collective view]

Area of Science:

• Pharmacology and Therapeutics
• Patient Care Management
• Health Policy

Background:

• Vitamin K antagonists (VKAs) were historically the primary anticoagulation method for atrial fibrillation and venous thromboembolisms.
• Care coordination faced challenges, particularly regarding interinstitutional continuity of care, leading to national standards (LSKA, LESA).
• The rise of direct oral anticoagulants (DOACs) has introduced new complexities in anticoagulation management and patient/caregiver support.

Purpose of the Study:

• To outline frameworks for responsible anticoagulation care in the evolving landscape of anticoagulant therapies.
• To address uncertainties in treatment coordination and follow-up for patients on anticoagulation.
• To provide guidance on managing the transition from VKAs to DOACs and ensuring continuous patient support.

Main Methods:

• Review of current anticoagulation care standards and practices.
• Analysis of challenges in coordinating care involving various healthcare providers.
• Examination of issues related to patient and caregiver support, including information accessibility and treatment switching.

Main Results:

• Existing initiatives like LSKA and LESA aim to improve anticoagulation care continuity.
• The increasing adoption of DOACs presents new challenges in treatment coordination and requires updated care frameworks.
• Clear guidelines are needed for follow-up organization, answering patient queries, and managing VKA to DOAC transitions.

Conclusions:

• Responsible anticoagulation care necessitates robust frameworks addressing coordination, follow-up, and communication.
• Adapting to the widespread use of DOACs is crucial for ensuring safe and effective anticoagulation management.
• Enhanced support systems are vital for patients and caregivers navigating complex anticoagulation therapies.